E-cadherin cell-adhesion molecule expression as a diagnostic adjunct in urothelial cytology

Diagnostic Cytopathology

Volumn 14, Issue 4, 1996, Pages 310-315

  Ross, Jeffrey S ^a,b   Cheung, Chhieng ^a   Sheehan, Christine ^a   Del Rosario, Arthur D ^a   Bui, Hai X ^a   Fisher, Hugh A G ^a  

^a STRATTON VA MEDICAL CENTER   (United States)

^b ALBANY MEDICAL CENTER   (United States)

Author keywords

E cadherin; Transitional cell carcinoma; Urothelial cytology

Indexed keywords

AVIDIN; BIOTIN; CELL ADHESION MOLECULE; MONOCLONAL ANTIBODY; PEROXIDASE; UVOMORULIN;

ADULT; AGED; ARTICLE; BIOPSY; BLADDER CARCINOMA; BLADDER IRRIGATION; CANCER CYTODIAGNOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTOSCOPY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, TRANSITIONAL CELL; CELL COMMUNICATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS; URINE; UROTHELIUM;

EID: 0029992323     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199605)14:4<310::AID-DC6>3.0.CO;2-J     Document Type: Article

References (34)

1. Whitmore WF Jr Bladder cancer: an overview CA 1988;38: 213-223.
2. Thompson IM The evaluation of microscopic hematuria: a population-based study. J Urol 1987;138:1189-1190.
3. Raghaven D, Shipley WU, Garnick MB, Russell PJ, Richie JP. Biology and management of bladder cancer. N Engl J Med 1990;322: 1129-1138
4. Koss LG Diagnostic cytology and its histopathologic bases. 4th ed. Philadelphia: JB Lippincott 1992:983-1015.
5. Shenoy UA, Colby TV, Schumann GB. Reliability of urinary cytodiagnosis in urothelial neoplasms. Cancer 1985;56:2041-2045.
6. Murphy WM. Current status of urinary cytology in the evaluation of bladder neoplasms. Hum Pathol 1990;21:886-896
7. Koss LG, Deith D, Ramanathan R, Sherman AB Diagnostic value of cytology of voided urine. Acta Cytol 1985;29:810-816.
8. Tribukait B, Gustafson H, Esposti MD. Ploidy and proliferation of human bladder tumors as measured by flow-cytofluorometric DNA-analysis and its relations to histopathology and cytology. Cancer 1979;43:1742-1751.
9. Badalament RA, Hermansen DK, Kimmel M, et al. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer 1987;60: 1423-1427.
10. Melamed MR, Traganos F, Sharpless T, Darznkiewicz Z. Urine cytology automation: preliminary studies with acndine orange stain and flow-through cytofluorometry. Invest Urol 1976;13:333-338.
11. Koss LG, Wersto RP, Simmons DA, Deitch D, Herz F, Freed SZ. Predictive value of DNA measurements in bladder washings. Comparison of flow cytometry, image cytophotometry, and cytology in patients with a past history of urothelial tumors. Cancer 1989;64: 916-924.
12. Walker KZ, Russell PJ, Kingsley EA, Philips J, Raghavan D. Detection of malignant cells in voided urine from patients with bladder cancer, a novel monoclonal assay. J Urol 1989;142:1578-1583
13. Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest 1993;68:4-17.
14. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HFM, Debruyne FMJ, Schalken JA. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 1993;53:3241-3245.
15. Ross JS, del Rosario AD, Figge HL, Sheehan C, Fisher HAG, Bui HX. E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder. Hum Pathol 1996; in press.
16. Gamallo C, Palacios J, Suarez A, et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 1993; 142:987-993.
17. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993;53:1696-1701.
18. Sommers CL, Thompson EW, Torri JA, Kemler R, Gelmann EP, Byers SW. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Cell Growth Differ 1991;2:365-372.
19. Dorudi S, Sheffield JP, Poulsom R, Northover JM, Hart IR. E-cadherin expression in colorectal cancer. An immunocytochemical and in-situ hybridization study. Am J Pathol 1993;142:981-986.
20. Pignatelli M, Liu D, Nasim MM, Stamp TW, Hirano S, Takeichi M. Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumor cells. Br J Cancer 1992;66:629-634.
21. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993;53:1690-1695.
22. Matsuura K, Kawanishi J, Fujii S, et al. Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid. Br J Cancer 1992;66:1122-1130.
23. Kinsella AR, Green B, Lepts GC, Hill CL, Bowie G, Taylor BA. The role of cell-cell adhesion molecule E-cadherin in large bowel tumour cell invasion and metastasis. Br J Cancer 1993;67:904-909.
24. Field JK. Oncogenes and tumor-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol 1992; 28.67-76.
25. Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res 1992;52:5770-5774.
26. + adenosine triphosphatase during mouse skin tumor progression. Am J Pathol 1992;140:1179-1185.
27. Tohma Y, Yamashima T, Yamashita J. Immunohistochemical localization of cell adhesion molecule epithelial cadherin in human arachnoid villi and meningiomas. Cancer Res 1992;52:1981-1987.
28. Inoue M, Ogawa H, Miyata M, Shiozaki H, Tanizawa O. Expression of E-cadherin in normal, benign, and malignant tissues of female genital organs. Am J Clin Pathol 1992;98:76-80.
29. Hashimoto M, Niwa O, Nitta Y, Takeichi M, Yokoro K. Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn J Cancer Res 1989;80:459-463.
30. Shimoyama Y, Hirohashi S. Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett 1991;52:131-135.
31. Bussemakers JM, van-Moorselaar RJ, Giroldi LA. Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res 1992;52:2916-2922.
32. Giroldi LA, Schalken JA. Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications. Cancer Metastasis Rev 1993;12: 29-37.
33. Umbas R, Schalken JA, Aalders TW, et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992;52:5104-5109.
34. Ross JS, Figge HL, Bui HX, et al E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage and clinical outcome. Mod Pathol 1994;7:835-841.